Trial Profile
A study to evaluate the determinants of dolutegravir plasma concentration in the clinical setting
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Dec 2016
Price :
$35
*
At a glance
- Drugs Dolutegravir (Primary) ; Atazanavir; Valproic acid
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 30 Dec 2016 New trial record